Protagonist Therapeutics
PTGX
PTGX
138 hedge funds and large institutions have $2.15B invested in Protagonist Therapeutics in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more funds holding
Funds holding: 127 → 138 (+11)
1.29% more ownership
Funds ownership: 101.2% → 102.48% (+1.3%)
53% less call options, than puts
Call options by funds: $1.11M | Put options by funds: $2.35M
Holders
138
Holding in Top 10
10
Calls
$1.11M
Puts
$2.35M
Top Buyers
| 1 | +$37.9M | |
| 2 | +$35.7M | |
| 3 | +$33.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.5M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| 1 | -$44M | |
| 2 | -$12M | |
| 3 | -$11.6M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$9.24M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$9.22M |